The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSchroder Income Growth Fund Regulatory News (SCF)

Share Price Information for Schroder Income Growth Fund (SCF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 283.00
Bid: 280.00
Ask: 285.00
Change: 0.00 (0.00%)
Spread: 5.00 (1.786%)
Open: 283.00
High: 0.00
Low: 0.00
Prev. Close: 283.00
SCF Live PriceLast checked at -
Schroder Income Growth is an Investment Trust

To provide real growth of income, being growth of income in excess of the rate of inflation, and capital growth as a consequence of the rising income primarily in UK equities.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Block Listing Application

20 Apr 2020 18:00

RNS Number : 2608K
Schroder Income Growth Fund PLC
20 April 2020
 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, TO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY MEMBER STATE OF THE EEA (OTHER THAN THE UNITED KINGDOM) OR TO ANY NATIONAL, RESIDENT OR CITIZEN OF THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY MEMBER STATE OF THE EEA (OTHER THAN THE UNITED KINGDOM)

 

20 April 2020

Schroder Income Growth Fund plc

Block Listing Application

 

The Board of Schroder Income Growth Fund plc (the "Company") announces that application has been made to the Financial Conduct Authority and to the London Stock Exchange for a block listing of 2,200,000 ordinary shares of ten pence each ("Ordinary Shares") in the Company to be admitted to the Official List and to trading on the London Stock Exchange's market for listed securities ("Admission").

 

The above 2,200,000 Ordinary Shares to be block listed may be issued pursuant to the Company's existing authorities to issue new Ordinary Shares on a non pre-emptive basis. These Ordinary Shares may be issued inter alia to satisfy market demand and for the purposes of managing the premium to net asset value (cum income) per Ordinary Share at which the Ordinary Shares are trading. When issued, these Ordinary Shares will rank pari passu with the existing Ordinary Shares in issue. It is expected that Admission will become effective on 22 April 2020.

 

The Company's LEI is: 549300X1RTYYP7S3YE39

Enquiries:

 

Schroder Investment Management Limited 

020 7658 6596

Matthew Riley

Peel Hunt LLP

020 7418 8900

Liz Yong, Luke Simpson, Tom Pocock (Corporate Broking)

Chris Bunstead, Ed Welsby (Sales)

 

Disclaimer

 

This announcement does not constitute a prospectus relating to the Company and does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any shares in the Company in any jurisdiction nor shall it, or any part of it, or the fact of its distribution, form the basis of, or be relied on in connection with or act as any inducement to enter into, any contract therefor.

 

Peel Hunt LLP ("Peel Hunt"), which is authorised and regulated by the Financial Conduct Authority, is acting for the Company only in connection with the matters described in this announcement and is not acting for or advising any other person, or treating any other person as their client, in relation thereto and will not be responsible for providing the regulatory protection afforded to clients of Peel Hunt or advice to any other person in relation to the matters contained herein.

 

The shares of the Company have not been and will not be registered under the US Securities Act of 1933, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements. Moreover, the shares of the Company have not been, nor will they be, registered under the applicable securities laws of Australia, Canada, the Republic of South Africa, Japan or any member state of the EEA (other than the United Kingdom). Further, the Company will not be registered under the US Investment Company Act of 1940, as amended. Subject to certain exceptions, the shares of the Company may not be offered or sold in the United States, Australia, Canada, the Republic of South Africa, Japan or any member state of the EEA (other than the United Kingdom) or to, or for the account or benefit of, any national, resident or citizen of the United States, Australia, Canada, the Republic of South Africa, Japan or any member state of the EEA (other than the United Kingdom). The share issuance programme, and the distribution of this announcement, in other jurisdictions may be restricted by law and the persons into whose possession this announcement comes should inform themselves about, and observe, any such restrictions.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ALSQBLFLBZLEBBE
Date   Source Headline
5th Mar 202410:17 amRNSNet Asset Value(s)
4th Mar 202412:38 pmRNSPortfolio Update
4th Mar 202411:07 amRNSNet Asset Value(s)
1st Mar 202410:46 amRNSNet Asset Value(s)
29th Feb 202410:59 amRNSNet Asset Value(s)
28th Feb 202410:50 amRNSNet Asset Value(s)
27th Feb 202410:31 amRNSNet Asset Value(s)
26th Feb 202410:48 amRNSNet Asset Value(s)
23rd Feb 202410:33 amRNSNet Asset Value(s)
22nd Feb 202410:50 amRNSNet Asset Value(s)
21st Feb 202410:27 amRNSNet Asset Value(s)
20th Feb 202410:23 amRNSNet Asset Value(s)
19th Feb 202410:38 amRNSNet Asset Value(s)
16th Feb 202410:35 amRNSNet Asset Value(s)
15th Feb 202410:48 amRNSNet Asset Value(s)
14th Feb 20244:10 pmRNSDirector/PDMR Shareholding
14th Feb 202410:43 amRNSNet Asset Value(s)
13th Feb 202411:13 amRNSNet Asset Value(s)
9th Feb 202410:18 amRNSNet Asset Value(s)
8th Feb 202410:41 amRNSNet Asset Value(s)
7th Feb 202410:16 amRNSNet Asset Value(s)
6th Feb 202411:54 amRNSDirector/PDMR Shareholding
6th Feb 202410:20 amRNSNet Asset Value(s)
5th Feb 202410:32 amRNSNet Asset Value(s)
2nd Feb 202410:42 amRNSNet Asset Value(s)
1st Feb 20244:20 pmRNSDirector/PDMR Shareholding
1st Feb 20241:01 pmRNSPortfolio Update
1st Feb 202410:41 amRNSNet Asset Value(s)
31st Jan 202410:21 amRNSNet Asset Value(s)
31st Jan 20247:00 amRNSKepler Trust Intelligence: New Research
30th Jan 202410:29 amRNSNet Asset Value(s)
29th Jan 202411:13 amRNSNet Asset Value(s)
26th Jan 202410:29 amRNSNet Asset Value(s)
25th Jan 202410:57 amRNSNet Asset Value(s)
24th Jan 202410:27 amRNSNet Asset Value(s)
23rd Jan 202411:09 amRNSNet Asset Value(s)
22nd Jan 202410:38 amRNSNet Asset Value(s)
19th Jan 202410:14 amRNSNet Asset Value(s)
18th Jan 202410:13 amRNSNet Asset Value(s)
17th Jan 202410:43 amRNSNet Asset Value(s)
16th Jan 202410:39 amRNSNet Asset Value(s)
15th Jan 202410:24 amRNSNet Asset Value(s)
12th Jan 202410:16 amRNSNet Asset Value(s)
11th Jan 202411:59 amRNSNet Asset Value(s)
10th Jan 202411:27 amRNSNet Asset Value(s)
9th Jan 202411:05 amRNSNet Asset Value(s)
8th Jan 202410:22 amRNSNet Asset Value(s)
5th Jan 20244:59 pmRNSPortfolio Update
5th Jan 202410:23 amRNSNet Asset Value(s)
4th Jan 202411:32 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.